Human herpesvirus 8, Kaposi's sarcoma, and associated conditions

Clinics in Laboratory Medicine

Volumn 22, Issue 4, 2002, Pages 883-910

  Gandhi, Monica ^a   Greenblatt, Ruth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; MALE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS REPLICATION; DISEASE TRANSMISSION; EPIDEMIOLOGY; HERPES VIRUS INFECTION; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; VIROLOGY;

HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036893373     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00023-9     Document Type: Review

References (216)

1. Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. Boshoff C, Chang Y. Kaposi's sarcoma-associated herpesvirus: A new DNA tumor virus. Ann Rev Med 2001;52:453-70.
3. Lacoste V, Mauclere P, Dubreuil G, Lewis J, Georges-Courbot M-C, Gessain A. KSHV-like herpesviruses in chimps and gorillas. Nature 2000;407:151-2.
4. Zong J-C, Ciufo D, Alcendor D, et al. High-level variability in ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999;73:4156-70.
5. Poole L, Zong J-C, Ciufo D, et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 1999;73:6646-60.
6. Moore P, Boshoff C, Weiss R, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
7. Cerimele F, Curreli F, Ely S, Friedman-Kien A, Cesarman E, Flore O. Kaposi's sarcomaassociated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol 2001;75:2435-43.
8. Blackbourn DJ, Lennette ET, Klencke B, et al. The restricted cellular host range of human herpesvirus 8. AIDS 2000;14:1123-33.
9. Foreman K, Friborg J, Kong W, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 1997;336:163-71.
10. Kedes D, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
11. Gao S-J, Kingsley L, Hoover D, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
12. Kedes D, Lagunoff M, Renne R, Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 1997;100:2606-10.
13. Simpson G, Schulz T, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-8.
14. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [see comments]. Nat Med 1996;2:925-8.
15. Lennette E, Blackbourn D, Levy J. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
16. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 1996;2:342-6.
17. Miller G, Rigsby M, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996;334:1292-7.
18. Smith M, Bloomer C, Horvat R, Goldstein E, Casparian J, Chandran B. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997;176:84-93.
19. Raab MS, Albrecht JC, Birkmann A, et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 1998;72:6725-31.
20. Chatlynne LG, Lapps W, Handy M, et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998;92:53-8.
21. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests HHV-8 Interlaboratory Collaborative Group [see comments]. J Infec Dis 1998;178:304-9.
22. Chandran B, Bloomer C, Chan SR, Zhu L, Goldstein E, Horvat R. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 1998;249:140-9.
23. Birkmann A, Mahr K, Ensser A, et al. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virology 2001;75:11583-93.
24. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 1999;256:381-92.
25. Spira TJ, Lam L, Dollard SC, et al. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000;38:2174-80.
26. Inoue N, Mar EC, Dollard SC, Pau CP, Zheng Q, Pellett PE. New immunofluorescence assays for detection of human herpesvirus 8-specific antibodies. Clin Diagn Lab Immunol 2000;7:427-35.
27. Collandre H, Ferris S, Grau O, Montagnier L, Blanchard A. Kaposi's sarcoma and new herpesvirus [letter]. Lancet 1995;345:1043.
28. Lefrère JJ, Meyohas MC, Mariotti M, Meynard JL, Thauvin M, Frottier J. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis 1996;174:283-7.
29. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. Aids 1996;10:175-80.
30. Whitby D, Howard M, Tenant-Flowers M, et al. Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
31. Boivin G, Gaudreau A, Routy JP. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. Aids 2000;14:1907-10.
32. Bigoni B, Dolcetti R, de Lellis L, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996;173:542-9.
33. Marchioli C, Love J, Abbott L, et al. Prevalence of human herpesvirus 8 DNA sequences in several patient populations. J Clin Microbiol 1996;34:2635-8.
34. Benfield TL, Dodt KK, Lundgren JD. Human herpesvirus-8 DNA in bronchoalveolar lavage samples from patients with AIDS-associated pulmonary Kaposi's sarcoma. Scandinavian J Infect Dis 1997;29:13-6.
35. Cathomas G, Tamm M, McGandy CE, Perruchoud AP, Mihatsch MJ, Dalquen P. Detection of herpesvirus-like DNA in the bronchoalveolar lavage fluid of patients with pulmonary Kaposi's sarcoma. Euro Res J 1996;9:1743-6.
36. Tamm M, Reichenberger F, McGandy CE, et al. Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Resp Crit Care Med 1998;157:458-63.
37. Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis 1998;177:213-6.
38. Boldogh I, Szaniszlo P, Wade A, et al. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis 1996;23:406-7.
39. Koelle D, Huang M, Vieira J. Detection of Kaposi's sarcoma associated herpesvirus in saliva of human immunodeficiency virus infected individuals with and without Kaposi's sarcoma. Abstract H084 presented at the 36th Intersciences Conference on Antimicrobial Antibiotic Chemotherapy, New Orleans, Louisiana, 1996.
40. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000;343:1369-77 [comment in: N Engl J Med 2000;343:1411-3; UI:20505234].
41. Pellett P, Spira T, Bagasra O, et al. Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol 1999;37:1298-301.
42. Viviano E, Vitale F, Ajello F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS 1997;11:607-12.
43. Boshoff C, Schulz T, Kennedy M. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995;1:1274-8.
44. Foreman KE, Bacon PE, Hsi ED, Nickoloff BJ. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest 1997;99:2971-8.
45. Li JJ, Huang YQ, Cockerell CJ, Friedman-Kien AE. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol 1996;148:1741-8.
46. Feuillard J, Aubin JT, Poirel L, et al. Detection rate and intratumoral virus load of human herpesvirus-8 in immunodeficiency-related B-cell lymphoid malignancies. J Med Virol 1997;53:277-81.
47. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma [see comments]. Lancet 1995;345:761-2.
48. Grandadam M, Dupin N, Calvez V, et al. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpevirus DNA load in peripheral blood mononuclear cells. J Infectious Dis 1997;175:1198-201.
49. Mendez JC, Procop GW, Espy MJ, Paya CV, Smith TF. Detection and semiquantitative analysis of human herpesvirus 8 DNA in specimens from patients with Kaposi's sarcoma. J Clin Microbiol 1998;36:2220-2.
50. Min J, Katzenstein DA. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels. Aids Res Hum Retro 1999;15:51-5.
51. White IE, Campbell TB. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 2000;38:1992-5.
52. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
53. Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 2000;38:1404-8.
54. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 2000;96:2069-73.
55. Decker LL, Shankar P, Khan G, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Experi Med 1996;184:283-8.
56. Katano H, Iwasaki T, Baba N. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 2000;74:3478-85.
57. Kedes D, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. J Am Med Assoc 1997;277:478-81.
58. Regamey N, Tamm M, Binet I, Thiel G, Erb P, Cathomas G. Transplantation-associated Kaposi's sarcoma: Herpesvirus 8 transmission through renal allografts. Transpl Proc 1999;31:922-3.
59. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: Epidemiology and risk factors. Cancer 2000;88:500-17.
60. Iscovich J, Fischbein A, Fisher-Fischbein J, et al. Seroprevalence of Kaposi's sarcomaassociated herpesvirus in healthy adults in Israel. Anticancer Res 2000;20:2119-22.
61. Sitas F, Newton R. Kaposi's sarcoma in South Africa. J Natl Cancer Inst Monogr 2001;28:1-4.
62. Challine D, Rougot-Thoraval F, Sarah T, et al. Seroprevalence of human herpesvirus 8 antibody in populatins at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 2001;41:1120-5.
63. Blackbourn D, Osmond D, Levy J, Lennette E, et al. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. J Infect Dis 1999;179:237-9.
64. Martin J, Ganem D, Osmond D, Page-Shafer K, Macrae D, Kedes D. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998;338:948-54.
65. Melbye M, Cook P, Hjalgrim H, et al. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998;77:543-8.
66. Grulich A, Kaldor J, Hendry O, Luo K, Bodsworth N, Cooper D. Risk of Kaposi's sarcoma and oroanal sexual contact. Am J Epidemiol 1997;145:673-9.
67. Greenblatt RM, Jacobson LP, Levine AM, et al. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis 2001;183:1130-4.
68. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection HIV Epidemiology Research Study Group. New Engl J Med 2001;344:637-43.
69. Calabrò ML, Fiore JR, Favero A, et al. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and seronegative women. J Infect Dis 1999;179:1534-7.
70. Lampinen TM, Kulasingam S, Min J, et al. Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women. J Infect Dis 2000;181:1785-90.
71. Rezza G, Capobianchi M, Serraino D, et al. HHV-8 Shedding among HIV-infected women. J Acquir Immune Defic Syndr 2001;28:103-4.
72. Whitby D, Smith N, Matthews S, et al. Human herpesvirus 8: Seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999;179:234-6.
73. Huang Y-Q, Li J, Poiesz B, Kaplan M, Friedman-Kien A. Detection of the herpesviruslike DNA sequences in matched specimens of semen and blood from patients with AIDS-related Kaposi's sarcoma by polymerase chain reaction in situ hybridization. Am J Pathol 1997;150:147-53.
74. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996;334:1168-72.
75. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996;10(Suppl A):S75-82.
76. Vitale F, Viviano E, Perna AM, et al. Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol and Infect 2000;125:671-5.
77. Gessain A, Mauclere P, van Beveren M, et al. The human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999;81:189-92.
78. Di Alberti L, Ngui S, Porter S, et al. Presence of human herpesvirus 8 variants in the oral tissues of human immunodeficiency virus-infected persons. J Infectious Dis 1997;175:703-7.
79. Koelle D, Huang M-L, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in Saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J Infect Dis 1997;176:94-102.
80. LaDuca JR, Love JL, Abbott LZ, Dube S, Freidman-Kien AE, Poiesz BJ. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J Infect Dis 1998;178:1610-5.
81. Serraino D, Locatelli M, Songini M, Franceschi S, Rezza G. Human herpes virus-8 infection among pregnant women and their children: Results from the Sardinia-IDDM Study 2. Int J Cancer 2001;91:740-1.
82. Blackbourn D, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy J. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997;349:609-11.
83. Allain JP. Emerging viral infections relevant to transfusion medicine. Blood Rev 2000;14:173-81.
84. Engels EA, Frisch M, Biggar RJ, Goedert JJ. AIDS-Related opportunistic illness and potent antiretroviral therapy [letter]. JAMA 2000;283:2653-4.
85. Operskalski EA, Busch MP, Mosley JW, Kedes DH. Blood donations and viruses [letter; comment]. Lancet 1997;349:1327.
86. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000;96:3279-81.
87. Nocera A, Corbellino M, Valente U, et al. Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor. Transplantation Proceedings 1998;30:2095-6.
88. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997;90:2826-9.
89. Regamey N, Tamm M, Wernli M, et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998;339:1358-63.
90. Kasolo F, Mpabalwani E, Gompels U. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997;78:847-56.
91. Milliancourt C, Barete S, Marcelin A, et al. Human herpesvirus-8 seroconversions after renal transplantation. Transplantation 2001;72:1319-37.
92. Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 2001;39:4269-73.
93. Mercader M, Nickoloff BJ, Foreman KE. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Arch Pathol Lab Med 2001;125:785-9.
94. Mercader M, Taddeo B, Panella JR, Chandran B, Nickoloff BJ, Foreman KE. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 2000;156:1961-71.
95. Huang LM, Chao MF, Chen MY, et al. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J Biol Chem 2001;276:13427-32.
96. Sternbach G, Varon J. Moritz Kaposi: Idiopathic pigmented sarcoma of the skin. J Emergency Med 1995;13:671-4.
97. Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi's sarcoma: A retrospective review of 125 cases from Northern Israel. J Euro Acad Dermatol Venereol 2000;14:91-5.
98. Papasteriades C, Kaloterakis A, Filiotou A, et al. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma. Tissue Antigens 1984;24:313-5.
99. Safai B. Kaposi's sarcoma: A review of the classical and epidemic forms. Proc NY Acad Sci 1984;437:373-82.
100. Taylor J, Smith P, Bull D, Pike M. Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 1972;26:483-97.
101. Taylor J, Templeton A, Vogel C, Ziegler J, Kyalwazi S. Kaposi's sarcoma in Uganda: A clinico-pathological study. Int J Cancer 1971;8:122-35.
102. Melbye M, Kestens L, Biggar R, Schreuder G, Gigase P. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: No association with HLA-DR5. Int J Canc 1987;39:182-4.
103. Stein M, Lachter J, Spencer D, et al. Variants of Kaposi's sarcoma in Southern Africa: A retrospective analysis (1980-1992). Acta Oncologica 1996;35:193-9.
104. Greenblatt R. Kaposi's sarcoma and human herpesvirus-8 Infect. Dis Clin N Am 1998;12:63-82.
105. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Tranplant 1993;12:S328-36.
106. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Academy of Dermat 1999;40:177-86.
107. Penn I, First M. Development and incidence of cancer following cyclosporine therapy. Transplant Proc 1986;18(2 Suppl):210-5.
108. Montagnino G, Lorca E, Tarantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: Comparison with normal population and with patients under dialytic treatment. Clin Transplantation 1996;10:461-9.
109. Farge D. Kaposi's sarcoma in organ transplant recipients: The collaborative transplantation research group of Ile de France. Eur J Med 1993;2:339-43.
110. Rinaldi M, Pellegrini C, D'Armini AM, et al. Neoplastic disease after heart transplantation: Single center experience European. J Cardio-Thoracic Surg 2001;19:696-701.
111. Gaspari AA, Marchese S, Powell D, Rady PL, Tyring SK. Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermat 1997;37:843-7.
112. Halpern SM, Parslew R, Cerio R, Kirby JT, Sharpe GR. Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid. British J Dermatol 1997;137:140-3.
113. Sato-Matsumura K, Matsumura T, Nabeshima M, Katano H, Sata T, Koizumi H. Serological and immunohistochemical detection of human herpesvirus 8 in Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid. British J Dermatol 2001;145:633-7.
114. Vandercam B, Lachapelle J, Janssens P, Tennstedt D, Lambert M. Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis. Dermatol 1996;194:180-2.
115. Frances C, Mouquet C, Calvez V. Human herpesvirus 8 and renal transplantation. N Engl J Med 1999;340:1045.
116. Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 2001;39:506-8.
117. Cattani P, Nanni G, Graffeo R, et al. Pretransplantation human herpesvirus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients. Transplantation Proceedings 2000;32:526-7.
118. Diociaiuti A, Nanni G, Cattani P, et al. HHV8 in renal transplant recipients. Transplant International 2000;13(Suppl 1):S410-2.
119. Doutrelepont JM, De Pauw L, Gruber SA, et al. Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence, Transplantation 1996;62:463-6.
120. Parravicini C, Lauri E, Baldini L, et al, Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997;278:1969-70.
121. Brunson M, Balakrishnan K, Penn. IHLA and Kaposi's sarcoma in solid organ transplantation, Hum Immunol 1990;29:56-63.
122. Gómez E, Aguado S, Rodriguez M, Alvarez-Grande J. Kaposi's sarcoma after renal transplantation - Disappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment [letter]. Nephrol Dial Transplant 1998;13:3279-80.
123. Nagy S, Gyulai R, Kemeny L, Szenohradszky P, Dobozy A. Iatrogenic Kaposi's sarcoma: HHV8 Positivity persists but the tumors regress almost completely without immunosuppressive therapy [letter]. Transplantation 2000;69:2230-1.
124. Sabeel A, Qunibi W. Recurrent Kaposi's sarcoma in a renal transplant recipient maintained on minimum doses of immunosuppression [letter]. Nephrology, Dialysis. Transplantation 1998;13:1609-10.
125. Vella J, Mosher R, Sayegh M. Kaposi's sarcoma after renal transplantation. N Engl J Med 1997;336:1761.
126. Colina F, Lopez-Rios F, Lumbreras C, Martinez-Laso J, Garcia IG, Moreno-Gonzalez E. Kaposi's sarcoma developing in a liver graft. Transplantation 1996;61:1779-81.
127. Markowitz GS, Williams GS, Chang Y, Hardy MA, Saouaf R, D'Agati VD. A novel etiology of renal allograft dysfunction. Am J Kidney Dis 2001;38:658-63.
128. Shaheen FA, al-Sulaiman MH, Ramprasad KS, al-Khader AA. Kaposi's sarcoma in renal transplant recipients. Ann Transpl 1997;2:49-58.
129. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. New Eng J Med 2000;343:1378-85 [comment in: N Engl J Med 2000;343:1411-3; UI:205052341].
130. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8. Leukemia 1999;13:664-70.
131. Biggar R, Horm J, Fraumeni J. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-1981. J Natl Cancer Inst 1984;73:89-94.
132. Biggar R, Rosenberg P, Cote T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int J Cancer 1996;68:754-8.
133. Beral V, Peterman T, Berkelman R, Jaffe H. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 1990;335:123-7.
134. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe H, Wiess R, editors. Cancer, HIV and AIDS. Cold Spring Harbor (NY): Cold Spring Harbor Press; 1991. p. 5-22.
135. Biggar R, Rabkin C. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin N Am 1996;5:997-1010.
136. Touloumi G, Kaklamanis L, Potouridou I, et al. The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 1997;70:538-41.
137. Cook-Mozaffari P, Newton R, Beral V, Burkitt DP. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998;78:1521-8.
138. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Euro J Canc 2001;37:1188-201.
139. Lifson AR, Darrow WW, Hessol NA, et al. Kaposi's sarcoma in a cohort of homosexual and bisexual men Epidemiology and analysis for cofactors. Am J Epidemiol 1990;131:221-31.
140. Rezza G, Dorrucci M, Serraino D, et al. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study Aids 2000;14:1647-53.
141. Veugelers P, Strathdee S, Moss A, et al. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the tricontinental seroconverter study. Epidemiol 1995;6:382-6.
142. Jones JL, Hanson DL, Dworkin MS, Jaffe HW. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 2000;24:270-4.
143. Lebbe C, Blum L, Pellet C, et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 1998;12:F45-9.
144. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and nonHodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study Swiss HIV Cohort Study. BMJ (Clinical Research Ed) 1999;319:23-4.
145. Gnann Jr JW, Pellett PE, Jaffe HW. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30(Suppl 1):S72-6.
146. Archibald C, Schechter M, Le T, Craib K, Montaner J, O'Shaughnessy M. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology 1992;3:203-9.
147. Giraldo G, Beth E, Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Nat Canc Inst 1972;49:1509-26.
148. Ambroziak J, Blackbourn D, Herndier B, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995;268:582-3.
149. Moore P, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
150. Schalling M, Ekman M, Kaaya E, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995;1:707-8.
151. Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis 1996;173:248-51.
152. Huang Y, Li J, Kaplan M, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
153. Lebbé C, Agbalika F, de Crémoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma [see comments]. Arch Dermatol 1997;133:25-30.
154. De Milito A, Catucci M, Venturi G, et al. Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells [letter]. Blood 1996;87:3521-2.
155. Foreman KE, Friborg J, Chandran B, et al. Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions. J Dermatol Sci 2001;26:182-93.
156. Dezube B. Clinical presentation and natural history of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin N Am 1996;10:1023-9.
157. Dezube BJ. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: Clinical features, staging, and treatment. Seminars in Oncology 2000;27:424-30.
158. Ioachim H, Adsay V, Giancotti F, Dorsett B, Melamed J. Kaposi's sarcoma of internal organs: A multiparameter study of 86 cases. Cancer 1995;75:1376-85.
159. Aboulafia DM. The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 2000;117:1128-45.
160. Kuhlman JE. Imaging pulmonary disease in AIDS: State of the art. European Radiol 1999;9:395-408.
161. Naidich D, Tarras M, Garay S, Birnbaum B, Ryback B, Schinella R. Kaposi's sarcoma CT-radiographic correlation. Chest 1989;96:723-8.
162. Hamm P, Judson M, Aranda C. Diagnosis of pulmonary Kaposi's sarcoma with fiberoptic bronchoscopy and endobronchial biopsy: A report of five cases. Cancer 1987;59:807-10.
163. White D. Pulmonary complications of HIV-associated malignancies. Clin Chest Med 1996;17:755-61.
164. Lassoued K, Clauvel J-P, Fegueux S, Matheron S, Gorin I, Oksenhendler E. AIDS-associated Kaposi's sarcoma in female patients. AIDS 1991;5:877-80.
165. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T07 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997;72:68-71.
166. Ciufo DM, Cannon JS, Poole LJ, et al. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: Formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 2001;75:5614-26.
167. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994;173:23-31.
168. Ensoli B, Sturzl M, Monini P, et al. Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv Cancer Res 2001;81:161-200.
169. Neipel F, Albrecht JC, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity? J Virol 1997;71:4187-92.
170. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997;71:839-42.
171. Gruffat H, Sergeant A, Manet E. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma. Microbes Infect 2000;2:671-80.
172. Burysek L, Yeow WS, Lubyova B, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 1999;73:7334-42.
173. Burysek L, Yeow WS, Pitha PM. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 1999;2:19-32.
174. Zimring JC, Goodbourn S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 1998;72:701-7.
175. Li M, Lee H, Yoon DW, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997;71:1984-91.
176. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997;390:184-7.
177. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn M, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385:347-50.
178. Thome M, Schneider P, Hofmann K, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997;386:517-21.
179. Schulz TF. KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Euro J Canc 2001;37:1217-26.
180. Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: A novel lymphoma entity. British J Haemat 1997;97:515-22.
181. Cesarman E, Chang Y, Moore P, Said J, Knowles D. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
182. Nador R, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.
183. Gessain A, Sudaka A, Brière J, et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: Is there any relevant association in non-human immunodeficiency virus-infected patients [letter; comment]? Blood 1996;87:414-6.
184. Soulier J, Grollet L, Okenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
185. Oksenhendler E, Cazals-Hatem D, Schulz T, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 1998;338:1585-90.
186. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science 1997;276:1851-4.
187. Tedeschi R, Kvarnung M, Knekt P, et al. A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma. Br J Cancer 2001;84:122-5.
188. Hjalgrim H, Frisch M, Melbye M. Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate. Br J Cancer 1998;78:419-20.
189. McDonagh D, Liu J, Gaffey M, Layfield L, Azumi N, Traweek S. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequences in angiosarcoma. Am J Pathol 1996;149:1363-8.
190. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996;87:3903-9.
191. Kapelushnik J, Ariad S, Benharroch D. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. British J Haematol 2001;113:425-8.
192. Whelan P, Scadden DT. New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma. Clin Dermatol 2000;18:469-77.
193. Kirova YM, Belembaogo E, Frikha H, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: A retrospective study of 643 cases. Radiother and Oncol 1998;46:19-22.
194. Krown S. Interferon-alpha and other biologic agents for the treatment of Kaposi's sarcoma. Hematol Oncol Clin N Am 1991;5:311-22.
195. Monini P, Sirianni MC, Franco M, et al. Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-alpha therapy: A case report. Clin Infect Dis 2001;33:1782-5.
196. Shepherd FA, Beaulieu R, Gelmon K, et al. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV Clinical Trials Network study. J Clin Oncol 1998;16:1736-42.
197. Northfelt DW, Dezube BJ, Thommes JA, et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J Clin Onc 1998;16:2445-51.
198. Welles L, Saville MW, Lietzau J, et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1998;16:1112-21.
199. Kedes D, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs: Implications for potential therapy. J Clin Invest 1997;99:2082-6.
200. Löw P, Neipel F, Rascu A, et al. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. European J Med Res 1998;3:461-4.
201. Hammoud Z, Parenti DM, Simon GL. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment [see comments]. Clini Infect Dis 1998;26:1233.
202. Mazzi R, Parisi S, Sarmati L, et al. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 2001;15:2061-2.
203. Simonart T, Noel JC, De Dobbeleer G, et al. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: Report of a case. J Med Virol 1998;55:215-8.
204. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from the Multicenter AIDS Cohort Study. J Infec Dis 1996;173:1477-80.
205. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group N Engl J Med 1999;340:1063-70.
206. Krischer J, Rutschmann O, Hirschel B, Vollenweider-Roten S, Saurat JH, Pechère M. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study. J Am Acad Dermat 1998;38:594-8.
207. Rizzieri D, Liu J, Traweek S, Miralles G. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 1997;349:775-6.
208. Amato RJ. Thalidomide: An antineoplastic agent. Curr Oncol Rep 2002;4:56-62.
209. Dockrell DH, Kinghorn GR. Imiquimod and resiquimod as novel immunomodulators. J Antimicrob Chemother 2001;48:751-5.
210. Hasan J, Jayson GC. VEGF antagonists. Expert Opin Biol Ther 2001;1:703-18.
211. Albini A, Morini M, D'Agostini F, et al. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res 2001;61:8171-8.
212. Cheer SM, Foster RH. Alitretinoin. Am J Clin Dermatol 2000;1:307-14 [discussion: 315-6].
213. Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 01% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2001;2:77-87.
214. Fingleton B, Matrisian LM. Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Curr Opin Oncol 2001;13:368-73.
215. Hermans P. Kaposi's sarcoma in HIV-infected patients: Treatment options. HIV Med 2000;1:137-42.
216. Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpevirus infection in immunocompetent children. JAMA 2002;287:1295-1300.